Select for export Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03693-w PubMed 41257994 Copy citation Copy BibTeX Translational Psychiatry 2025-11-12 Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.96718 PubMed 41393631 Copy citation Copy BibTeX Cureus 2025-11-11 Aung Phyo Oo, Sarah Tseu, Arvind Ponnusamy OpenAlex Published psilocybin AddictionChronic PainBrain Imaging Other More
Select for export Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-025-02272-3 PubMed 41224969 Copy citation Copy BibTeX Neuropsychopharmacology 2025-11-11 Hannah M. Kramer, Meghan Hibicke, Jason W. Middleton, Alaina M. Jaster, Jesper L. Kristensen, Charles D. Nichols OpenAlex Published psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Other More
Select for export ‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain No abstract availability was recorded for this entry. Details DOI 10.1038/s41583-025-00999-y PubMed 41219396 Copy citation Copy BibTeX Nature reviews. Neuroscience 2025-11-10 Sian Lewis OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other More
Select for export Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression” No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2025.120637 PubMed 41224017 Copy citation Copy BibTeX Journal of Affective Disorders 2025-11-10 Max Wolff, Samuli Kangaslampi OpenAlex Published psilocybin DepressionChronic PainPharmacology Other More
Select for export Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.5c07092.s001 Copy citation Copy BibTeX Figshare 2025-11-09 Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723) OpenAlex Published psilocybinpsilocin DepressionToxicity Clinical Trial More
Select for export Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2025.2583960 PubMed 41214462 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2025-11-09 Nicky J. Mehtani, Maha N. Mian, Gabrielle Agin-Liebes, Allison R. Coker, Christopher Huebner, B. Anderson OpenAlex Published psilocybin AddictionMechanism of ActionWellbeing Qualitative Study More
Select for export Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.5c07092 PubMed 41322617 Copy citation Copy BibTeX ACS Omega 2025-11-09 Luisina Castelli Rodríguez, Guillermo Morera, Sandra Lupo, Danilo Davyt, Ignacio Carrera, Gonzalo Hernández Dossi OpenAlex Published psilocybinpsilocin DepressionToxicity Clinical Trial More
Select for export The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1523/jneurosci.0652-25.2025 PubMed 41213805 Copy citation Copy BibTeX Journal of Neuroscience 2025-11-09 Sarah N. Magee, Allison C. Sereno, Maria Echeveste-Sanchez, Elizabeth G. Shannon, Abir Mohsin, Sarah E. Mott OpenAlex Published psilocybinpsilocin AddictionPharmacologyMechanism of Action Animal Study More
Select for export The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2025.2583967 PubMed 41208129 Copy citation Copy BibTeX Journal of psychoactive drugs 2025-11-08 Zech JM, Richard J, Jones GM PubMed Published psilocybin AddictionMechanism of ActionRandomized Controlled Trial Randomized Controlled Trial More
Select for export Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.11.06.687023 Copy citation Copy BibTeX bioRxiv 2025-11-06 Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2025.09.011 PubMed 41205366 Copy citation Copy BibTeX Unknown journal 2025-11-06 Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export A single dose of psilocybin alleviates chronic pain and associated anxiety and depression in mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1036/1097-8542.br2511031 Copy citation Copy BibTeX Unknown journal 2025-11-05 AccessScience Editors OpenAlex Published psilocybin DepressionAnxietyChronic Pain Animal Study More
Select for export Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice. No abstract availability was recorded for this entry. Details DOI 10.1038/s41398-025-03729-1 PubMed 41198613 Copy citation Copy BibTeX Unknown journal 2025-11-05 Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM Europe PMC Published psilocybin Animal Study Animal Study More
Select for export Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm No abstract availability was recorded for this entry. Details DOI 10.5167/uzh-292276 Copy citation Copy BibTeX Universität Zürich, ZORA 2025-11-04 Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider OpenAlex Published psilocybin DepressionAnxietyBrain Imaging Other More
Select for export Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required No abstract availability was recorded for this entry. Details DOI 10.1007/s40267-025-01199-5 Copy citation Copy BibTeX Drugs & Therapy Perspectives 2025-11-04 Aisling McGuigan OpenAlex Published psilocybin DepressionAddictionChronic Pain Randomized Controlled Trial More
Select for export Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-04 Yale University ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionNeuroplasticity Other More
Select for export A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-04 University of Washington ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-7890051/v1 Copy citation Copy BibTeX Research Square 2025-11-04 Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionNeuroplasticityMechanism of Action Animal Study More
Select for export Psilocybin and chronic neuropathic pain: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/rapm-2024-105532 PubMed 39106989 Copy citation Copy BibTeX Unknown journal 2025-11-04 Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T Europe PMC Published psilocybin Chronic PainAgingSystematic Review Systematic Review More
